Clinical Trial Update: TVMR With the Innovalve System Trial - TWIST-BE TWIST-PILOT-BE [NA]

View source ↗

Summary

The TWIST-BE TWIST-PILOT-BE trial evaluating the Innovalve System for mitral valve regurgitation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation

Drugs mentioned

• Innovalve System

Snippet

Sponsor: Innovalve Bio Medical Ltd. | Conditions: Mitral Valve Regurgitation (Degenerative or Functional) | NA | Status: WITHDRAWN